Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Edward Richardson

ResearcherPublications, citations & collaboration network

Edward Richardson is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 16 works, 118 citations, an h-index of 6 and an i10-index of 3.

16
Works
118
Citations
6
h-index
3
i10-index

How has Edward Richardson's publication output changed over time?

ScholarIQpublication output · 2019–2025

Output grew0% over the shown period — from 1 works in 2019 to 1 in 2025.

1
3
3
2
1
20192020202120242025

What are the most-cited papers on Edward Richardson?

ScholarIQmost cited works
Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?
Pedro Castro, Marta Palomo, Ana Belén Moreno‐Castaño, Sara Fernández, Sergi Torramadé‐Moix, Georgina Pascual, Julia Martínez-Sánchez, Edward Richardson, Adrián Téllez, Josep M. Nicolás, Enric Carreras, Paul G. Richardson, Juan J. Badimón, Ginés Escolar, Maribel Díaz‐Ricart
S131791641. 202151 CitationsOPEN ACCESS
Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes
Edward Richardson, David García‐Bernal, Eleonora Calabretta, Rubén Jara, Marta Palomo, Rebecca M. Baron, Gregory A. Yanik, Jawed Fareed, Israël Vlodavsky, Massimo Iacobelli, Maribel Díaz‐Ricart, Paul G. Richardson, Carmelo Carlo‐Stella, José M. Moraleda
S149756942. 202116 CitationsOPEN ACCESS
Response to Maccio et al, “Multifactorial pathogenesis of COVID‐19‐related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?”
Edward Richardson, Carmelo Carlo‐Stella, Rubén Jara, Israël Vlodavsky, Massimo Iacobelli, Jawed Fareed, Clifton C. Mo, Peter O’Gorman, Gregory A. Yanik, Marta Palomo, Maribel Díaz‐Ricart, José M. Moraleda
S164469042. 202012 CitationsOPEN ACCESS
Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide
Clifton C. Mo, Edward Richardson, Eleonora Calabretta, Francesco Corrado, Mehmet H. Kocoglu, Rebecca M. Baron, Jean M. Connors, Massimo Iacobelli, L. J. Wei, Aaron P. Rapoport, Maribel Díaz‐Ricart, José M. Moraleda, Carmelo Carlo‐Stella, Paul G. Richardson
S169446993. 20248 CitationsOPEN ACCESS
Circulating Biomarkers of COVID-19-Triggered Endotheliopathy: From Conjecture to Certainty
Ana Belén Moreno‐Castaño, Sara Fernández, Marta Palomo, Patricia Molina, Julia Martínez-Sánchez, Sergi Torramadé‐Moix, Helena Ventosa, Ferran Seguí, Ginés Escolar, Enric Carreras, José M. Nicolás, Edward Richardson, David García‐Bernal, Carmelo Carlo‐Stella, José M. Moraleda, Paul G. Richardson, Maribel Díaz‐Ricart, Pedro Castro
Blood. 20207 CitationsOPEN ACCESS

Related on ScholarIQ

St Helier Hospital
Institution
Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?
Paper
Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes
Paper
Response to Maccio et al, “Multifactorial pathogenesis of COVID‐19‐related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?”
Paper
Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide
Paper
Circulating Biomarkers of COVID-19-Triggered Endotheliopathy: From Conjecture to Certainty
Paper
470M+ articles · free account